<DOC>
	<DOCNO>NCT00638183</DOCNO>
	<brief_summary>Since Spiriva Inhalation Capsules 18mcg ( hereinafter product ) indicate treatment patient chronic obstructive pulmonary disease ( i.e . patient chronic bronchitis pulmonary emphysema ) usually intend long-term use , present survey conduct collect safety effectiveness information use product long period time daily clinical setting , obtain proper drug use information .</brief_summary>
	<brief_title>Special Survey Long-term Treatment With Tiotropium COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>1 . Patients Chronic Obstructive Pulmonary Disease 2 . Patients expect use product long period time 1 . Patients glaucoma 2 . Patients micturition disorder due prostatic hyperplasia etc . 3 . Patients history hypersensitivity atropine derivative component product</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>